1 Min Read
Nov 14 (Reuters) - Medicenna Therapeutics Corp
* Medicenna presents clinical data from previous phase 1 and 2 clinical trials of mdna55 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.